CING/ 06/02/2026 · 9:54 AM FDA Delays Cingulate’s ADHD Drug Approval – But No Safety or Efficacy Issues FDA asked Cingulate to fix manufacturing details for ADHD drug; no safety issues. Company will update and resubmit soon.
